This data set includes tables on persons living with HIV/AIDS, newly diagnosed HIV cases and all cause deaths in HIV/AIDS cases by gender, age, race/ethnicity and transmission category. In all tables, cases are reported as of December 31 of the given year, as reported by January 9, 2019, to allow a minimum of 12 months reporting delay. Gender is determined by both current gender and sex at birth variables; transgender values are assigned when current gender is identified as "Transgender" or when a discrepancy is identified between a person's sex at birth and their current gender (e.g., cases where sex at birth is "Male" and current gender is "Female" will become Transgender: Male to Female.) Prior to 2003, Asian and Native Hawaiian/Pacific Islanders were classified as one combined group. In order to present these race/ethnicities separately, living cases recorded under this combined classification were split and redistributed according to their expected proportional population representation estimated from post-2003 data.

Statistics relating to HIV infection

Data Series: Number of new HIV infections per 1,000 uninfected population, by sex and age Indicator: III.8 - Number of new HIV infections per 1,000 uninfected population, by sex, age and key populations Source year: 2023 This dataset is part of the Minimum Gender Dataset compiled by the United Nations Statistics Division. Domain: Health and related services

Context

The New York City Department of Health and Mental Hygiene publishes mid-year and annual HIV surveillance reports each year. This dataset is taken from these reports and includes data gathered from 2011 to June 30, 2016.

Content

This dataset includes HIV infections and AIDS diagnoses, viral suppression in persons living with diagnosed HIV infection (PLWDHI), deaths of those with diagnosed HIV infection, and other statistics from 2011 to 2015 in New York City boroughs.

Purpose

The data contained here shows trends in age, gender, and geographic demographics over time for HIV infections in NYC, and this can be used to visualize the prevalence of the virus in the city.

Acknowledgement

This data was pulled from NYC's OpenData at https://data.cityofnewyork.us/Health/DOHMH-HIV-AIDS-Annual-Report/fju2-rdad .

United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data was reported at 0.500 % in 2014. This stayed constant from the previous number of 0.500 % for 2013. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data is updated yearly, averaging 0.500 % from Dec 2008 (Median) to 2014, with 7 observations. The data reached an all-time high of 0.500 % in 2014 and a record low of 0.500 % in 2014. United States US: Prevalence of HIV: Total: % of Population Aged 15-49 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV.; ; UNAIDS estimates.; Weighted Average;

United States US: Incidence of HIV: per 1,000 Uninfected Population data was reported at 0.110 Ratio in 2019. This stayed constant from the previous number of 0.110 Ratio for 2018. United States US: Incidence of HIV: per 1,000 Uninfected Population data is updated yearly, averaging 0.120 Ratio from Dec 2010 (Median) to 2019, with 10 observations. The data reached an all-time high of 0.130 Ratio in 2012 and a record low of 0.110 Ratio in 2019. United States US: Incidence of HIV: per 1,000 Uninfected Population data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Social: Health Statistics. Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.;UNAIDS estimates.;Weighted average;This is the Sustainable Development Goal indicator 3.3.1 [https://unstats.un.org/sdgs/metadata/].

This dataset contains death counts, crude rates and adjusted rates for selected causes of death by county and region. For more information, check out: http://www.health.ny.gov/statistics/vital_statistics/, or go to the "About" tab.

Human Immunodeficiency Virus (HIV) remains a significant public health concern, with adults being at greater risk. Thus, understanding the dynamics of HIV transmission is crucial for effective prevention and control strategies, hence the need for a continuous clinical survey of the patients’ records of diagnosis and treatment for HIV. The data include the quarterly records of 138 adults diagnosed with HIV at Osun State University Teaching Hospital, Nigeria which involves the number of adults tested positive and negative for each of the endogenous variables discussed below. Information was sought using a convenient sampling method, which entails careful selection of individual records based on availability. The data was grouped into quarterly records of the diagnosed adults, with an average age ranging between 26 years and 52 years, and spread between the years 2008 and 2021. The records comprise 72 Females and 66 Males while the presence of each symptom is coded as 1 and the absence coded as 0. The endogenous variables observed in the clinical records of the surveyed patients are Fever (F), Diarrhea (D), Abdominal pain (AP), Skin rash (SR), Mouth sour (MS), Cellulitis (C), Coughing with sputum (CS), Loss of appetite (LA), Genital infections (GI), Medical fitness (MF), Headache (H), Catarrh (CA), Weight Loss (WL), Excessive Sweat (ES), Mouth Sour (MS), and Body weakness (BW). The impacts of these aforementioned factors would be examined on the spread of HIV. The clinical survey revealed that 77 individuals (55.80%) did not experience fever, while 61 (44.20%) did. Diarrhea was reported by 39 participants (28.26%), leaving 99 (71.74%) without this symptom. Abdominal pain and cellulitis were both reported by only 4 individuals (2.90%), with 134 participants (97.10%) indicating no occurrences of these symptoms. In terms of medical fitness, 110 individuals (79.71%) reported no fitness issues, whereas 28 (20.29%) reported having some. Cough with sputum affected 50 participants (36.23%), while 88 (63.77%) did not report this symptom. Headaches were almost universally absent, with 137 individuals (99.28%) not experiencing any. Catarrh was present in 14 participants (10.14%), with 124 (89.86%) reporting no instances. Loss of appetite was reported by 5 individuals (3.62%), and skin rashes were observed in 28 participants (20.29%). Weight loss affected 49 individuals (35.51%), and excessive sweating was reported by 137 participants (99.28%). Mouth soreness was noted in 27 participants (19.57%), while genital infections were reported by 6 individuals (4.35%). Body weakness was reported by 49 participants (35.51%). In the age distribution, 56 individuals (40.58%) fall into the young adult’s category while 82 individuals (59.42%) are categorized as older adults. Notably, all participants in the study were confirmed to be HIV positive, emphasizing a focused analysis of this group’s health characteristics.

HIV notification rate per million population

Distribution of Singapore Residents with HIV/AIDS by Mode of Transmission

Distribution of Singapore Residents with HIV/AIDS by Gender

Distribution of Singapore Residents with HIV/AIDS by Ethnic Groups

Series Name: Number of new HIV infections per 1 000 uninfected population by sex and age (per 1 000 uninfected population)Series Code: SH_HIV_INCDRelease Version: 2021.Q2.G.03 This dataset is the part of the Global SDG Indicator Database compiled through the UN System in preparation for the Secretary-General's annual report on Progress towards the Sustainable Development Goals.Indicator 3.3.1: Number of new HIV infections per 1,000 uninfected population, by sex, age and key populationsTarget 3.3: By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseasesGoal 3: Ensure healthy lives and promote well-being for all at all agesFor more information on the compilation methodology of this dataset, see https://unstats.un.org/sdgs/metadata/

People aged 15 to 59 years seen at HIV services in the UK, expressed as a rate per 1,000 population.Data is presented by area of residence, and exclude people diagnosed with HIV in England who are resident in Wales, Scotland, Northern Ireland or abroad.RationaleThe geographical distribution of people seen for HIV care and treatment is not uniform across or within regions in England. Knowledge of local diagnosed HIV prevalence and identification of local risk groups can be used to help direct resources for HIV prevention and treatment.In 2008, http://www.bhiva.org/HIV-testing-guidelines.aspx recommended that Local Authority and NHS bodies consider implementing routine HIV testing for all general medical admissions as well as new registrants in primary care where the diagnosed HIV prevalence exceeds 2 in 1,000 population aged 15 to 59 years.In 2017, guidelines were updated by https://www.nice.org.uk/guidance/NG60 which is co-badged with Public Health England. This guidance continues to define high HIV prevalence local authorities as those with a diagnosed HIV prevalence of between 2 and 5 per 1,000 and extremely high prevalence local authorities as those with a diagnosed HIV prevalence of 5 or more per 1,000 people aged 15 to 59 years.When this is applied to national late HIV diagnosis data, it shows that two-thirds of late HIV diagnoses occur in high-prevalence and extremely-high-prevalence local authorities. This means that if this recommendation is successfully applied in high and extremely-high-prevalence areas, it could potentially affect two-thirds of late diagnoses nationally.Local authorities should find out their diagnosed prevalence published in UKHSA's http://fingertips.phe.org.uk/profile/sexualhealth , as well as that of surrounding areas and adapt their strategy for HIV testing using the national guidelines.Commissioners can use these data to plan and ensure access to comprehensive and specialist local HIV care and treatment for HIV diagnosed individuals according to the http://www.medfash.org.uk/uploads/files/p17abl6hvc4p71ovpkr81ugsh60v.pdf and http://www.bhiva.org/monitoring-guidelines.aspx .Definition of numeratorThe number of people (aged 15 to 59 years) living with a diagnosed HIV infection and accessing HIV care at an NHS service in the UK and who are resident in England.Definition of denominatorResident population aged 15 to 59.The denominators for 2011 to 2023 are taken from the respective 2011 to 2023 Office for National Statistics (ONS) revised population estimates from the 2021 Census.Further details on the ONS census are available from the https://www.ons.gov.uk/census .CaveatsData is presented by geographical area of residence. Where data on residence were unavailable, residence have been assigned to the local health area of care.Every effort is made to ensure accuracy and completeness of the data, including web-based reporting with integrated checks on data quality. The overall data quality is high as the dataset is used for commissioning purposes and for the national allocation of funding. However, responsibility for the accuracy and completeness of data lies with the reporting service.Data is as reported but rely on ‘record linkage’ to integrate data and ‘de-duplication’ to prevent double counting of the same individual. The data may not be representative in areas where residence information is not known for a significant proportion of people accessing HIV care.Data supplied for previous years are updated on an annual basis due to clinic or laboratory resubmissions and improvements to data cleaning. Data may therefore differ from previous publications.Values are benchmarked against set thresholds and categorised into the following groups: <2 (low), 2 to 5 (high) and≥5 (extremely high). These have been determined by developments in national testing guidelines.The data reported in 2020 and 2021 is impacted by the reconfiguration of sexual health services during the national response to COVID-19.

This dataset contains death counts and crude rates by region, age group, and selected cause of death. For more information, check out: http://www.health.ny.gov/statistics/vital_statistics/, or go to the "About" tab.

Rate: Number of deaths (per 100,000) due to HIV disease

Definition: Deaths with human immunodeficiency virus (HIV) disease as the underlying cause (ICD-10 codes: B20-B24).

Data Sources:

(1) Centers for Disease Control and Prevention, National Center for Health Statistics

(2) Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health

(3) Population Estimates, State Data Center, New Jersey Department of Labor and Workforce Development

Dataset refers to the Statistics Relating to Notification of HIV Aids Cases and Deaths in Mauritius for the year 2000 to 2021

This shapefile provides HIV statistics by state that can be used in conjunction with the co-morbidities risk profile to provide more nuance on levels of risk by state. Note that values of 0 mean there is no data for that particular state.The source of data for HIV prevalence rates is the Nigeria Institute for Health Metrics and Evaluation (IHME), HIV Prevalence Geospatial Estimates 2000-2017.

Dataset from Singapore Department of Statistics. For more information, visit https://data.gov.sg/datasets/d_6d8bcb5f8e9cf2616b758c53095768fb/view

ART not only saves lives but also gives a chance for people living with HIV/AIDS to live long lives. Without ART very few infected people survive beyond ten years.1

Today, a person living in a high-income country who started ART in their twenties can expect to live for another 46 years — that is well into their 60s.2

While the life expectancy of people living with HIV/AIDS in high-income countries has still not reached the life expectancy of the general population, we are getting closer to this goal.3

The combination of antiretroviral drugs which make-up ART have progressively improved. Recent research shows that a person who started ART in the late 1990s would be expected to live ten years less than a person who started ART in 2008.4 This increase goes beyond the general increase in life expectancy in that period and reflects the improvements in ART — fewer side effects, more people following the prescribed treatment, and more support for the people in need of ART.

Laos LA: Incidence of HIV: per 1,000 Uninfected Population data was reported at 0.140 Ratio in 2022. This stayed constant from the previous number of 0.140 Ratio for 2021. Laos LA: Incidence of HIV: per 1,000 Uninfected Population data is updated yearly, averaging 0.150 Ratio from Dec 1990 (Median) to 2022, with 33 observations. The data reached an all-time high of 0.170 Ratio in 2013 and a record low of 0.010 Ratio in 1993. Laos LA: Incidence of HIV: per 1,000 Uninfected Population data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Laos – Table LA.World Bank.WDI: Social: Health Statistics. Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.;UNAIDS estimates.;Weighted average;This is the Sustainable Development Goal indicator 3.3.1 [https://unstats.un.org/sdgs/metadata/].

The ultimate goal of HIV treatment is to achieve viral suppression, which means the amount of HIV in the body is very low or undetectable. This is important for people with HIV to stay healthy, have improved quality of life, and live longer. People living with HIV who maintain viral suppression have effectively no risk of passing HIV to others. Texas DSHS is the source of this data. Diagnosed- received a diagnosis of HIV Linked to care-visited an HIV heath care provider within 1 month (30 days) after learning they were HIV positive Received- or were retained in care** received medical care for HIV infection Viral suppression- their HIV “viral load” – the amount of HIV in the blood – was at a very low level.